| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Adenosine deaminase 2 (243-293 aa) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:1000-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
ADA2 |
| Gene ID: |
51816 |
| Uniprot ID: |
ADA2_HUMAN |
| Immunogen Region: |
243-293 aa |
| Specificity: |
This antibody detects endogenous levels of human CECR1 |
| Immunogen: |
Synthesized peptide derived from the human CECR1 at the amino acid range 243-293 |
| Function | Adenosine deaminase that may contribute to the degradation of extracellular adenosine, a signaling molecule that controls a variety of cellular responses. Requires elevated adenosine levels for optimal enzyme activity. Binds to cell surfaces via proteoglycans and may play a role in the regulation of cell proliferation and differentiation, independently of its enzyme activity. |
| Protein Name | Adenosine Deaminase 2Cat Eye Syndrome Critical Region Protein 1 |
| Database Links | Reactome: R-HSA-5683826Reactome: R-HSA-6798695 |
| Cellular Localisation | Secreted |
| Alternative Antibody Names | Anti-Adenosine Deaminase 2 antibodyAnti-Cat Eye Syndrome Critical Region Protein 1 antibodyAnti-ADA2 antibodyAnti-ADGF antibodyAnti-CECR1 antibodyAnti-IDGFL antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
